Clinical Trial of CD38 Monoclonal Antibody Combined With Chemotherapy for T-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT07585734 · WITHDRAWN
Trial details
- NCT number
- NCT07585734
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2026-04-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.